Axoltis Pharma to participate in ENCALS 2026 and present preliminary SEALS study results
We are pleased to announce Axoltis Pharma’s participation in the ENCALS 2026 Meeting and the TRICALS satellite meeting, which will take place from June 24–26, 2026, at the Palacio Municipal de Congresos in Madrid, Spain. ENCALS is the leading European scientific meeting dedicated to amyotrophic lateral sclerosis (ALS), bringing together clinicians, researchers, patient organizations and … Continued